Trial intelligence / Profile preview

Atorvastatin and Pulmonary Pressure in COPD-related Pulmonary Hypertension

IRCT2013051213299N1Phase 3Completed

Sponsor
Vice chancellor for research of Arak University of Medical Sciences
Start
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of atorvastatin in chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH), sponsored by Vice chancellor for research of Arak University of Medical Sciences. Started Aug 2013; status: completed.

02

Drugs

atorvastatin
03

Conditions

chronic obstructive pulmonary disease (COPD)pulmonary hypertension (PH)

Beyond the preview

Go deeper on IRCT2013051213299N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013051213299N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call